Alcheme Bio develops precision enzyme systems that improve the flavor, functionality, and commercial value of protein ingredients. Its Nutralase® platform uses targeted enzyme processing to address off-notes, enhance ingredient performance, and unlock value from underutilized protein-rich materials. The company collaborates with ingredient manufacturers and food innovators to develop scalable solutions for food, feed, and specialty nutrition. Alcheme Bio was founded by Vanessa Small, PhD, MBA, who brings more than 20 years of experience in biotechnology, biochemistry, and product innovation. Her work bridges science and commercialization, translating advances in enzyme-enabled protein processing into higher-value ingredient solutions.